Karuna Therapeutics KRTX signed a definitive merger agreement with Bristol Myers Squibb BMY. Per the agreement terms, Bristol Myers will acquire all outstanding shares of Karuna for $330 per share in ...

Karuna Therapeutics was almost bought out by another large pharma that competed up until the last moment before Bristol Myers Squibb’s $14 billion proposal won out. The other multinational ...

Shares of Karuna Therapeutics KRTX have surged 98.7% in the past month against the industry’s 1.6% decline. One of the main reasons for this rise in stock price is management’s announcement of ...

Bristol Myers, in its second major takeover of the year, will buy the schizophrenia and Alzheimer’s drugmaker Karuna Therapeutics for $14 billion. Bristol Myers said it would pay $330 a share cash for ...

Shares of Karuna Therapeutics Inc. KRTX rocketed 48% into record territory in premarket trading Friday, after the biopharmaceutical company announced an agreement to be bought by Bristol Myers Squibb ...

After launching on its maiden voyage in April, Seaport Therapeutics and its crew of Karuna veterans have loaded up with $225 million in series B funds to support the journey to key clinical milestones ...

Read full article: Walgreens to pay up to $350 million in opioid settlement, includes whistleblower compensation JSO drug evidence from a raid on a home in the Arlington area. FILE - In this June 15, ...